Mehrnaz Mehrabani

Dr. Mehrnaz Mehrabani

Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MNMohammad Hadi Nematollahi
Mohammad Hadi Nematollahi
APAbbas Pardakhty
Abbas Pardakhty
MTMasoud Torkzadeh-Mahanai
Masoud Torkzadeh-Mahanai
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
GAG.R. Asadi
G.R. Asadi
Recently, the self-assembly property of nonionic surfactants has been utilized to create vesicles as alternatives to liposomes. The aims of the present study were to investigate the impact of cholesterol on niosome bilayer properties and to evaluate niosome solubilization by Triton X-100 (TR) in the presence and absence of cholesterol. Niosomes were prepared using Span 80 and Tween 80 with or without cholesterol, and several structural studies were done. We compared both types of niosomes in their rigidity, permeability, surface tension, thermal properties, toxicity profile, and solubilization by the addition of several aliquots of TR. Efforts to achieve solubilizing parameters are also discussed. Our results indicate that cholesterol in niosomes increases membrane stability, decreases the fluidity of the membrane and also alters membrane permeability. Additionally, the solubilization process is illustrated by a three-stage model, in which the vesicle-to-micelle transition for niosomes is induced by the stepwise addition of TR. We show that cholesterol-containing niosomes need a higher amount of TR concentration for solubilization. To our best knowledge, this is the first report on niosome solubilization with TR. The results revealed the similarity of niosomal to liposomal systems, and we hope this encourages researchers to design more solubilization and protein reconstitution studies with niosomes.

2 September 2015 in Cell Proliferation
Verified
Journal Article
Closed access
PDF file
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
MNMohammad Najafi
Mohammad Najafi
TKTunku Kamarul
Tunku Kamarul
KMKamran Mansouri
Kamran Mansouri
MIM. Iranpour
M. Iranpour
ASAli mohammad Sharifi
Ali mohammad Sharifi

5 October 2017 in Journal of Asian Natural Products Research
Verified
Journal Article
Closed access
HGHabib Ghaznavi
Habib Ghaznavi
IFIman Fatemi
Iman Fatemi
HKHeibatullah Kalantari
Heibatullah Kalantari
STSeyed Mohammad Taghi Hosseini Tabatabaei
Seyed Mohammad Taghi Hosseini Tabatabaei
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
MGMehdi Goudarzi
Mehdi Goudarzi
The major side effect of gentamicin (GEN) is nephrotoxicity which in turn restricts the clinical use of this drug. In this study, the effect of gallic acid (GA) on gentamicin-induced nephrotoxicity was studied. A total number of 28 male Wistar rats were randomly divided into four experimental groups: control, GEN (100 mg/kg/day), GEN + GA (30 mg/kg/day), GA (30 mg/kg/day). All drug administrations were done intraperitoneally (i.p) for eight consecutive days. Twenty-four hours after the last administration, blood samples were collected to determine serum creatinine (Cr), blood urea nitrogen (BUN). The right kidney was used for histological examination. Malondialdehyde (MDA), glutathione (GSH), nitric oxide (NO) levels and catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) activity were assayed in left renal tissue. Results showed a significant increase in the levels of MDA, NO, Cr, and BUN and decrease of GSH, CAT, GPx, and SOD by GEN administration. Co-administration with GA showed reduction in the levels of MDA, NO, Cr, and BUN and increase in GSH, CAT, GPx, and SOD. Also, the nephroprotective effect of GA was confirmed by the histological examination of the kidneys. The results of our study showed that GA exerts a significant nephroprotective effect against GEN-induced nephrotoxicity.

1 July 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SJSeyed Ali Javad-Mousavi
Seyed Ali Javad-Mousavi
AHAli Asghar Hemmati
Ali Asghar Hemmati
SMSaeed Mehrzadi
Saeed Mehrzadi
AHAzam Hosseinzadeh
Azam Hosseinzadeh
GHGholamreza Houshmand
Gholamreza Houshmand
MGMehdi Goudarzi
Mehdi Goudarzi

1 July 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SMSaeed Mehrzadi
Saeed Mehrzadi
NBNosrat Bahrami
Nosrat Bahrami
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
MMManijeh Motevalian
Manijeh Motevalian
EMEsrafil Mansouri
Esrafil Mansouri
MGMehdi Goudarzi
Mehdi Goudarzi

29 January 2020 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
MMMehrnaz Mehrabani
Mehrnaz Mehrabani
MGMehdi Goudarzi
Mehdi Goudarzi
SMSaeed Mehrzadi
Saeed Mehrzadi
ASAmir Siahpoosh
Amir Siahpoosh
MMMasoud Mohammadi
Masoud Mohammadi
AMAlireza Malayeri
Alireza Malayeri